HSBC Holdings
TVGN icon

HSBC Holdings’s Tevogen Bio Holdings TVGN Stock Holding History

HSBC Holdings’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,824
Closed -$13.8M – 3102
2022
Q4 		$13.8M Buy
26,824
+2,493
+10% +$1.28M 0.02% 795
2022
Q3 		$12.3M Hold
24,331
– – 0.02% 763
2022
Q2 		$12.2M Buy
+24,331
New +$12.2M 0.02% 795

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's TVGN Position: Q1 2023 in Review

HSBC Holdings sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 26,824 shares — an estimated $13.8M sold.

HSBC Holdings first reported a position in TVGN in Q2 2022 and held it in 3 quarters. The position peaked at $13.8M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • HSBC Holdings reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 26,824 Tevogen Bio Holdings shares in Q1 2023, an estimated $13.8M.
  • HSBC Holdings first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 3 quarters.
  • HSBC Holdings's Tevogen Bio Holdings position peaked at $13.8M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.